Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 118, Issue 4, 2016, Pages 610-620

  Kwok, Chun Shing ^a,b   Tiong, Denise ^c   Pradhan, Ashish ^c   Andreou, Andreas Y ^d   Nolan, James ^a,b   Bertrand, Olivier F ^e   Curzen, Nick ^f   Urban, Philip ^g   Myint, Phyo K ^h   Zaman, Azfar G ⁱ   Loke, Yoon K ^j   Mamas, Mamas A ^a,b  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^c ROYAL PRESTON HOSPITAL   (United Kingdom)

^d LIMASSOL GENERAL HOSPITAL   (Cyprus)

^e LAVAL UNIVERSITY   (Canada)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g LA TOUR HOSPITAL   (Switzerland)

^h UNIVERSITY OF ABERDEEN   (United Kingdom)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

^j UNIVERSITY OF EAST ANGLIA   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADVERSE OUTCOME; ANEMIA; BLEEDING; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; EMBASE; FOLLOW UP; HEART INFARCTION; HEART REINFARCTION; HEMATOCRIT; HUMAN; MEDLINE; MORTALITY RISK; MULTICENTER STUDY (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; CORONARY ARTERY DISEASE; META ANALYSIS; METABOLISM; MORTALITY; MYOCARDIAL INFARCTION; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; RISK FACTOR;

ANEMIA; CORONARY ARTERY DISEASE; HEMOGLOBINS; HUMANS; MORTALITY; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 84990193336     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.05.059     Document Type: Review

References (30)

1. 1 Tsujita, K., Nikolsky, E., Lansky, A.J., Dangas, G., Fahy, M., Brodie, B.R., Dudek, D., Mockel, M., Ochala, A., Mehran, R., Stone, G.W., Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Am J Cardiol 105 (2010), 1385–1394.
2. 2 Voeltz, M.D., Patel, A.D., Feit, F., Fazel, R., Lincoff, A.M., Manoukian, S.V., Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol 99 (2007), 1513–1517.
3. 3 Nikolsky, E., Aymong, E.D., Halkin, A., Grines, C.L., Cox, D.A., Garica, E., Mehran, R., Tcheng, J.E., Griffin, J.J., Guagliumi, G., Stuckey, T., Turco, M., Cohen, D.A., Negoita, M., Lansky, A.J., Stone, G.W., Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 44 (2004), 547–553.
4. 4 Kim, T.H., Koh, Y.S., Chang, K., Seo, S.M., Kim, C.J., Park, H.J., Kim, P.J., Her, S.H., Kim, D.B., Lee, J.M., Park, C.S., Kim, H.Y., Yoo, K.D., Jeon, D.S., Park, J.H., CHung, W.S., Seugn, K.B., Improved anemia is associated with favorable long-term clinical outcomes in patients undergoing PCI. Coron Artery Dis 23 (2012), 391–399.
5. 5 Kitai, Y., Ozasa, N., Morimoto, T., Bao, B., Furukawa, Y., Nakagawa, Y., Kadota, K., Yanagita, M., Shizuta, S., Kimura, T., Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention. Int J Cardiol 168 (2013), 5221–5228.
6. 6 Dundar, C., Oduncu, V., Erkol, A., Tanalp, A.C., Sirma, D., Karagoz, A., Karabay, C.Y., Kilicgedik, A., Pala, S., Tigen, K., Izqi, A., Kirma, C., In-hospital prognostic value of hemoglobin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing primary angioplasty. Clin Res Cardiol 101 (2012), 37–44.
7. 7 Nikolsky, E., Mehran, R., Aymong, E.D., Mintz, G.S., Lansky, A.J., Lasic, Z., Negoita, M., Fahy, M., Pocock, S.J., Na, Y., Krieger, S., Moses, J.W., Stone, G.W., Leon, M.B., Dangas, G., Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 94 (2004), 1023–1027.
8. 8 Pilgrim, T., Vetterli, F., Kalesan, B., Stefanini, G.G., Raber, L., Stortecky, S., Gloekler, S., Binder, R.K., Wenaweser, P., Moschovitis, A., Khattab, A.A., Buellesfeld, L., Zwahlen, M., Meier, B., Juni, P., Windecker, S., The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. Circ Cardiovasc Interv 5 (2012), 202–210.
9. 9 Maluenda, G., Lemesle, G., Collins, S.D., Ben-Dor, I., Syed, A.I., Torguson, R., Kaneshige, K., Xue, Z., Pakala, R., Suddath, W.O., Satler, L.F., Kent, K.M., Lindsay, J., Pichard, A.D., Waksman, R., The clinical significance of hematocrit values before and after percutaneous coronary intervention. Am Heart J 158 (2009), 1024–1030.
10. 10 Hosseini, S.K., Ansari, M.J., Lotfi Tokaldany, M., Sharafi, A., Hakki Kazazi, E., Poorhosseini, H., Association between preprocedural hemoglobin level and 1-year outcome of elective percutaneous coronary intervention. J Cardiovasc Med 15 (2014), 331–335.
11. 11 Lee, P.C., Kini, A.S., Ahsan, C., Fisher, E., Sharma, S.K., Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 44 (2004), 541–546.
12. 12 Valente, S., Lazzeri, C., Chiostri, M., Sori, A., Giglioli, C., Gensini, G.F., Prior and new onset anemia in ST-elevation myocardial infarction: a different prognostic role?. Intern Emerg Med 6 (2011), 329–336.
13. 13 Poludasu, S., Marmur, J.D., Weedon, J., Khan, W., Cavusoglu, E., Effect of hemoglobin level on long-term all-cause mortality after percutaneous coronary intervention in African-Americans. Am J Cardiol 103 (2009), 1078–1082.
14. 14 Matsue, Y., Matsumura, A., Abe, M., Ono, M., Seya, M., Nakamura, T., Iwatsuka, R., Mizukami, A., Setoguchi, M., Nagahori, W., Ohno, M., Suzuki, M., Hashimoto, Y., Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients. Heart Vessels 28 (2013), 19–26.
15. 15 Manzano-Fernandez, S., Marin, F., Martinez, J.A., Cambronero, F., Valdes, M., Ruiz-Nodar, J.M., Perez-Berbel, P., Lip, G.Y., Anemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting. QJM 101 (2008), 749–751.
16. 16 Halkin, A., Singh, M., Nikolsky, E., Grines, C.L., Tcheng, J.E., Garcia, E., Cox, D.A., Turco, M., Stuckey, T.D., Na, Y., Lansky, A.J., Gersh, B.J., O'Neill, W.W., Mehran, R., Stone, G.W., Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45 (2005), 1397–1405.
17. 17 Rao, S.V., McCoy, L.A., Spertus, J.A., Krone, R.J., Singh, M., Gitzgerald, S., Peterson, E.D., An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv 6 (2013), 897–904.
18. 18 Mehta, S.K., Frutkin, A.D., Lindsey, J.B., House, J.A., Spertus, J.A., Rao, S.V., Ou, F.S., Roe, M.T., Peterson, E.D., Marso, S.P., Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv 2 (2009), 222–229.
19. 19 Rathod, K.S., Jones, D.A., Rathod, V.S., Bromage, D., Guttmann, O., Gallagher, S.M., Mohiddin, S., Rothman, M.T., Knight, C., Jain, A.K., Kapur, A., Mathur, A., Timmis, A.D., Amersey, R., Wragg, A., Prognostic impact of anemia on patients with ST-elevation myocardial infarction treated by primary PCI. Coron Artery Dis 25 (2014), 52–59.
20. 20 Ioannidis, J.P., Trikalinos, T.A., The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ 176 (2010), 1091–1096.
21. 21 Davies, H.T., Crombie, I.K., Tavakoli, M., When can odds ratios mislead?. BMJ 316 (1998), 989–991.
22. 22 Kwok, C.S., Rao, S.V., Myint, P.K., Keavney, B., Nolan, J., Ludman, P.F., de Belder, M.A., Loke, Y.K., Mamas, M.A., Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis. Open Heart, 1, 2014, e000021.
23. 23 Hanna, E.B., Alexander, K.P., Chen, A.Y., Roe, M.T., Funk, M., Saucedo, J.F., Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction undergoing an invasive strategy according to hemoglobin levels. Am J Cardiol 111 (2013), 1099–1103.
24. 24 Authors/Task Force Members, Windecker, S., Kolh, P., Alfonso, F., Collet, J.P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S.J., Juni, P., appetein, A.P., Kastrati, A., Knuuti, J., Landmesser, U., Laufer, G., Neumann, F.J., Richter, D.J., Schauerte, P., Sousa Uva, M., Stefanini, G.G., Taggart, D.P., Torracca, L., Valvimigli, M., Wijns, W., Witkowski, A., 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35 (2014), 2541–2619.
25. 25 Urban, P., Meredith, I.T., Abizaid, A., Pocock, S.J., Carrie, D., Naber, C., Lipiecki, J., Richardt, G., Iniquez, A., Brunel, P., Valdes-Chavarri, M., Garot, P., Talwar, S., Berland, J., Abdellaoui, M., Eberli, F., Oldroyd, K., Zambahari, R., Gregson, J., Greene, S., Stoll, H.P., Morice, M.C., Polymer-free drug-coated coronary stents in patients at high bleeding risk. New Engl J Med 373 (2015), 2038–2047.
26. 26 Kwok, C.S., Sherwood, M.W., Watson, S.M., Nasir, S.B., Sperrin, M., Nolan, J., Kinnaird, T., Kiatchoosakun, S., Ludman, P.F., de Belder, M.A., Rao, S.V., Mamas, M.A., Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis. JACC Cardiovasc Interv 8 (2015), 436–446.
27. 27 Mamas, M.A., Fath-Ordoubadi, F., Danzi, G.B., Spaepen, E., Kwok, C.S., Buchan, I., Peek, N., de Belder, M.A., Ludman, P.F., Paunovic, D., Urban, P., Prevalence and impact of co-morbidity burden as defined by the Charlson Co-morbidity Index on 30-day and 1- and 5-year outcomes after coronary stent implantation (from the Nobori-2 study). Am J Cardiol 116 (2015), 364–371.
28. 28 Sherwood, M.W., Wang, Y., Curtis, J.P., Peterson, E.D., Rao, S.V., Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention. JAMA 311 (2014), 836–843.
29. 29 Carson, J.L., Brooks, M.M., Abbott, J.D., Chaitman, B., Kelsey, S.F., Triulzi, D.J., Srinivas, V., Menegus, M.A., Marroquin, O.C., Rao, S.V., Noveck, H., Passano, E., Hardison, R.M., Smitherman, T., vagonescu, T., Wimmer, N.J., William, D.O., Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 165 (2013), 964–971 e1.
30. 30 Kwok, C.S., Khan, M.A., Rao, S.V., Kinnaird, T., Sperrin, M., Buchan, I., de Belder, M.A., Ludman, P.F., Nolan, J., Loke, Y.K., Mamas, M.A., Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysis. Circ Cardiovasc Interv, 8, 2015, 10.1161/CIRCINTERVENTIONS.114.001645.